Summary

KEY FINDINGS
The Canada magnetic resonance imaging (MRI) systems market size is valued at $297.69 million as of 2026 and is expected to reach $497.58 million by 2034, progressing with a CAGR of 6.63% during the forecast years, 2026-2034.

MARKET INSIGHTS
Canada's publicly funded healthcare system, combined with provincial government procurement programs, establishes a unique framework for MRI systems market development. Health Canada regulates medical device safety and effectiveness through the Medical Devices Regulations (SOR/98-282), ensuring rigorous quality standards for magnetic resonance imaging equipment.
The country continues facing persistent MRI capacity constraints and extended wait times that drive ongoing system installations across hospital networks. Provincial health ministries coordinate diagnostic imaging infrastructure investments through strategic capital planning processes.
Moreover, Canada's aging population creates sustained demand for advanced diagnostic imaging services, particularly neurological and oncological examinations. Federal and provincial funding programs support healthcare infrastructure modernization, including diagnostic equipment replacement initiatives. Furthermore, technology advancements in scan speed and image quality improve operational efficiency, enabling higher patient throughput with existing equipment.
Rising cancer prevalence and neurological disorder incidence increase MRI scan volumes nationwide, placing additional pressure on already constrained imaging capacity. Additionally, workforce challenges, including radiologist and technician shortages, limit scanning capacity despite strong equipment availability.
Canada's universal healthcare system operates through provincial and territorial health insurance plans, providing comprehensive coverage for medically necessary services. Public hospitals administered by regional health authorities deliver the majority of MRI examinations through centrally managed imaging departments. However, wait times for non-urgent MRI scans frequently extend several months in many jurisdictions, creating patient access challenges.
Private diagnostic imaging clinics operate alongside public facilities, offering expedited services for patients willing to pay out-of-pocket or through employer-sponsored insurance. Provincial governments establish capital equipment budgets allocating funds for MRI system acquisitions based on population needs and utilization projections. Moreover, lengthy procurement cycles involving competitive tendering processes, clinical specification development, and budget approval sequences slow equipment deployment timelines.
Health technology assessment organizations evaluate clinical evidence supporting new imaging technologies before provincial reimbursement decisions. Furthermore, rural and remote regions face infrastructure limitations, including inadequate electrical systems, restricted space availability, and helium supply challenges. Mobile MRI services provide temporary solutions, delivering imaging capabilities to underserved communities through scheduled visits. Additionally, interprovincial coordination initiatives promote equipment sharing agreements and referral protocols, optimizing resource utilization.

SEGMENTATION ANALYSIS
The Canada magnetic resonance imaging (MRI) systems market is segmented into architecture, field type, and application. The field type segment is further categorized into high field systems, low-mid field systems, and ultra high field systems.
3T MRI systems, under the high field system segment, demonstrate accelerating market penetration across Canada, driven by enhanced diagnostic capabilities for complex clinical applications. These high-field strength systems deliver superior image resolution and signal-to-noise ratios compared to conventional 1.5T platforms. Academic medical centers and tertiary care hospitals prioritize 3T system acquisitions supporting advanced neuroimaging, cardiac imaging, and research applications.
Moreover, 3T technology enables specialized sequences, including functional MRI, diffusion tensor imaging, and high-resolution vessel wall imaging that enhance diagnostic precision. Cancer centers particularly value 3T systems for detailed tumor characterization and treatment planning applications. Radiologists increasingly recognize 3T advantages for detecting subtle pathology missed by lower field strength systems.
Furthermore, 3T systems support abbreviated imaging protocols, maintaining diagnostic quality while reducing scan times substantially. Provincial procurement committees evaluate the total cost of ownership, comparing 3T premium pricing against clinical value propositions. Research institutions leverage 3T platforms for translational neuroscience investigations and technology development initiatives.
Additionally, 3T systems demonstrate strong performance in musculoskeletal imaging applications, including cartilage assessment and small joint evaluation. Consequently, 3T magnetic resonance imaging systems represent strategic investments positioning facilities for future clinical and research requirements.

COMPETITIVE INSIGHTS
Some of the top players operating in the Canada magnetic resonance imaging (MRI) systems market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corp, Fujifilm Holdings Corporation, Esaote SpA, etc.
Philips Healthcare, operating under Koninklijke Philips NV, maintains a substantial presence throughout the Canadian MRI systems market as a leading medical technology innovator. The company manufactures comprehensive magnetic resonance imaging portfolios, including the Ingenia series featuring advanced patient comfort designs and workflow optimization technologies.
Philips emphasizes clinical partnerships with Canadian hospitals and research institutions, developing specialized imaging applications tailored to local clinical needs. Their BlueSeal magnet technology virtually eliminates helium boil-off requirements, reducing operational costs and environmental impact significantly. Moreover, Philips integrates artificial intelligence throughout the imaging workflow from patient positioning through automated image reconstruction and analysis.
The company's SmartSpeed technology accelerates scanning procedures without compromising diagnostic image quality. Philips maintains service networks across Canadian provinces, ensuring responsive technical support and preventive maintenance for installed equipment. Additionally, the company actively participates in Canadian healthcare conferences and professional organizations, strengthening relationships with radiologist communities nationwide.

COMPANY PROFILES
1. CANON MEDICAL SYSTEMS CORPORATION
2. ESAOTE SPA
3. FUJIFILM HOLDINGS CORPORATION
4. GE HEALTHCARE
5. PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS NV)
6. SIEMENS HEALTHINEERS

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. CANADA’S MRI SYSTEMS MARKET IS DRIVEN PRIMARILY BY PUBLIC HEALTHCARE SPENDING AND PROVINCIAL GOVERNMENT PROCUREMENT PROGRAMS
2.5.2. THE COUNTRY CONTINUES TO FACE MRI CAPACITY CONSTRAINTS AND LONG WAIT TIMES, WHICH ARE SUPPORTING NEW SYSTEM INSTALLATIONS
2.5.3. DEMAND FOR HIGH FIELD MRI SYSTEMS IS RISING DUE TO INCREASING COMPLEXITY OF NEUROLOGICAL AND ONCOLOGY DIAGNOSTICS
2.5.4. TECHNOLOGY MODERNIZATION INITIATIVES ARE DRIVING REPLACEMENT OF AGING MRI SYSTEMS ACROSS HOSPITAL NETWORKS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CANCER AND NEUROLOGICAL DISORDERS IS INCREASING MRI SCAN VOLUMES NATIONWIDE
3.1.2. FEDERAL AND PROVINCIAL FUNDING PROGRAMS ARE SUPPORTING THE EXPANSION OF DIAGNOSTIC IMAGING CAPACITY
3.1.3. AGING POPULATION AND GROWING CHRONIC DISEASE BURDEN ARE SUSTAINING LONG-TERM MRI DEMAND
3.1.4. ADVANCEMENTS IN SCAN SPEED AND IMAGE QUALITY ARE IMPROVING OPERATIONAL EFFICIENCY AND UTILIZATION
3.2. KEY RESTRAINTS
3.2.1. BUDGETARY LIMITATIONS AND LENGTHY PROCUREMENT CYCLES SLOW THE PACE OF MRI SYSTEM DEPLOYMENT
3.2.2. SHORTAGES OF RADIOLOGISTS AND TRAINED TECHNICIANS RESTRICT SCANNING CAPACITY DESPITE HIGH DEMAND
3.2.3. INFRASTRUCTURE LIMITATIONS IN RURAL AND REMOTE REGIONS REDUCE EQUITABLE ACCESS TO MRI SERVICES
3.2.4. HIGH INSTALLATION AND UPGRADE COSTS CHALLENGE RAPID TECHNOLOGY ADOPTION
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. INCREASING INVESTMENT IN HIGH-FIELD MRI SYSTEMS IS ENHANCING CLINICAL DIAGNOSTIC CAPABILITIES
4.1.2. USE OF AI-ENABLED WORKFLOW OPTIMIZATION TOOLS IS REDUCING BACKLOGS AND IMPROVING REPORTING SPEED
4.1.3. EXPANSION OF MRI OPERATING HOURS IS BEING USED TO ADDRESS WAIT TIME PRESSURES
4.1.4. GREATER EMPHASIS ON SYSTEM RELIABILITY AND LIFECYCLE COST MANAGEMENT IS INFLUENCING PURCHASING DECISIONS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR CANADA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MAGNETIC COIL MANUFACTURING
4.6.2. MAGNET AND COMPONENT SUPPLY
4.6.3. MRI SYSTEM ASSEMBLY
4.6.4. SOFTWARE & AI INTEGRATION
4.6.5. DISTRIBUTION & LOGISTICS
4.6.6. INSTALLATION & VALIDATION
4.6.7. TRAINING & MAINTENANCE SERVICES
4.6.8. AFTERMARKET SUPPORT
4.7. KEY BUYING CRITERIA
4.7.1. IMAGE QUALITY & RESOLUTION
4.7.2. TOTAL COST OF OWNERSHIP
4.7.3. PATIENT COMFORT FEATURES
4.7.4. SERVICE & TECHNICAL SUPPORT
4.8. REGULATORY FRAMEWORK
5. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY ARCHITECTURE
5.1. CLOSED MRI SYSTEMS
5.1.1. STANDARD BORE MRI SYSTEMS
5.1.2. WIDE BORE MRI SYSTEMS
5.2. OPEN MRI SYSTEMS
6. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY FIELD TYPE
6.1. HIGH FIELD SYSTEMS
6.1.1. 1.5T SYSTEM
6.1.2. 3T SYSTEM
6.2. LOW-MID FIELD SYSTEMS
6.3. ULTRA HIGH FIELD SYSTEMS
7. MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET BY APPLICATION
7.1. BRAIN AND NEUROLOGY MRI SYSTEM
7.2. SPINE AND MUSCULOSKELETAL MRI SYSTEM
7.3. PELVIC AND ABDOMINAL MRI SYSTEM
7.4. ONCOLOGY MRI SYSTEM
7.5. VASCULAR MRI SYSTEM
7.6. CARDIOLOGY MRI SYSTEM
7.7. PEDIATRIC MRI SYSTEM
7.8. GASTROENTEROLOGY MRI SYSTEM
7.9. OTHER APPLICATIONS
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. CANON MEDICAL SYSTEMS CORP
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCTS
8.2.1.3. STRENGTHS & CHALLENGES
8.2.2. ESAOTE SPA
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCTS
8.2.2.3. STRENGTHS & CHALLENGES
8.2.3. FUJIFILM HOLDINGS CORPORATION
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCTS
8.2.3.3. STRENGTHS & CHALLENGES
8.2.4. GE HEALTHCARE
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCTS
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS NV)
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCTS
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. SIEMENS HEALTHINEERS
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCTS
8.2.6.3. STRENGTHS & CHALLENGES





















LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
TABLE 2: MARKET BY ARCHITECTURE, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 3: MARKET BY ARCHITECTURE, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 4: MARKET BY CLOSED MRI SYSTEMS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 5: MARKET BY CLOSED MRI SYSTEMS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 6: MARKET BY FIELD TYPE, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 7: MARKET BY FIELD TYPE, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 8: MARKET BY HIGH FIELD SYSTEMS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 9: MARKET BY HIGH FIELD SYSTEMS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 10: MARKET BY APPLICATION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 12: KEY PLAYERS OPERATING IN THE CANADIAN MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CANADA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY ARCHITECTURE, IN 2025
FIGURE 9: CLOSED MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: SEGMENT GROWTH POTENTIAL, BY CLOSED MRI SYSTEMS, IN 2025
FIGURE 11: STANDARD BORE MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: WIDE BORE MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: OPEN MRI SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: SEGMENT GROWTH POTENTIAL, BY FIELD TYPE, IN 2025
FIGURE 15: HIGH FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: SEGMENT GROWTH POTENTIAL, BY HIGH FIELD SYSTEMS, IN 2025
FIGURE 17: 1.5T SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 18: 3T SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: LOW-MID FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: ULTRA HIGH FIELD SYSTEMS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 22: BRAIN AND NEUROLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 23: SPINE AND MUSCULOSKELETAL MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: VASCULAR MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: PELVIC AND ABDOMINAL MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 26: ONCOLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: CARDIOLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: PEDIATRIC MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: GASTROENTEROLOGY MRI SYSTEM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 30: OTHER APPLICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)